Circulation

Vol. 151, Issue 23 Issue 23 2025
9
Articles

Articles in this Issue

Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial

Nikolaus Marx, John E. Deanfield, Johannes F.E. Mann et al. Jun 10, 2025 pp. 1639-1650 10.1161/circulationaha.125.074545

BACKGROUND: Both GLP-1 (glucagon-like peptide-1) receptor agonists and SGLT2 (sodium-glucose cotransporter-2) inhibitors (SGLT2i) improve cardiovascular outcomes in people with typ...

Letter by Pan et al Regarding Article, “Complete Versus Culprit-Only Revascularization in Older Patients With ST-Segment–Elevation Myocardial Infarction: An Individual Patient Meta-Analysis”

Daorong Pan, Wen Wu, Mingxing Chen Jun 10, 2025 10.1161/circulationaha.124.073406

Revisiting the Open Vein Hypothesis to Reduce the Postthrombotic Syndrome: Implications for Multidisciplinary Care and Research: A Scientific Statement From the American Heart Association

Wenzhu Li, Suresh Vedantham, Farouc A. Jaffer et al. Jun 10, 2025 10.1161/cir.0000000000001330

The “open vein hypothesis” postulates that early thrombus clearance and restoration of venous blood flow may prevent postthrombotic syndrome after proximal deep vein thrombosis. Since its proposal sev...

Response by Campo and Pavasini to Letter Regarding Article, “Complete Versus Culprit-Only Revascularization in Older Patients With ST-Segment–Elevation Myocardial Infarction: An Individual Patient Meta-Analysis”

Gianluca Campo, Rita Pavasini Jun 10, 2025 10.1161/circulationaha.125.074587

Lymphatic Endothelial Branched-Chain Amino Acid Catabolic Defects Undermine Cardiac Lymphatic Integrity and Drive HFpEF

Xiong Guo, Chong Huang, Ling Zhang et al. Jun 10, 2025 pp. 1651-1666 10.1161/circulationaha.124.071741

BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) has become the most prevalent type of heart failure, but effective treatments are lacking. Cardiac lymphatics play a cruc...

New Classification to Describe Clinical Presentation in Aortic Stenosis: Stable, Progressive, and Acute Valve Syndrome

Philippe Généreux, Brian R. Lindman, Philippe Pibarot Jun 10, 2025 pp. 1627-1629 10.1161/circulationaha.125.074251

FMO2 Prevents Pathological Cardiac Hypertrophy by Maintaining the ER-Mitochondria Association Through Interaction With IP3R2-Grp75-VDAC1

Changchen Xiao, Chao Wang, Jingyi Wang et al. Jun 10, 2025 pp. 1667-1685 10.1161/circulationaha.124.072661

BACKGROUND: Cardiac hypertrophy, as an important pathological change, contributes to heart failure. Recent studies indicate that the mitochondria-associated endoplasmic reticulum membranes...

Loss of Methyltransferase and Hypomethylated m6A Sarcomere Transcripts Leading to Early-Onset Dilated Cardiomyopathy

Sophie Marie Hand, Yi Zhao, Donna Li et al. Jun 10, 2025 pp. 1692-1695 10.1161/circulationaha.124.072516

Two-Year Outcomes of Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation: The TRILUMINATE Pivotal Randomized Controlled Trial

Saibal Kar, Raj R. Makkar, Brian K. Whisenant et al. Jun 10, 2025 pp. 1630-1638 10.1161/circulationaha.125.074536

BACKGROUND: One-year outcomes of TRILUMINATE Pivotal (Trial to Evaluate Cardiovascular Outcomes in Patients Treated With the Tricuspid Valve Repair System Pivotal) found that transcatheter...

All Issues

Journal Info

Publisher Lippincott Williams & Wilkins
ISSN 0009-7322
E-ISSN 1524-4539
Subject Health Sciences
Language English
View Full Journal Page